Time | First trial treated cases (n=33) | Second trial treated cases (n=74) | First and second trial controls (n=59) |
End of treatment | 6 (18%)2-150 | 10 (13%)** | 2 (3%) |
Six months after stopping treatment | 9 (27%)2-151 | 23 (31%)†† | 5 (8%) |
12 months after stopping treatment | 9 (27%)2-152 | 25 (34%)‡‡ | 8 (13.5%) |